Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
高級檢索
  • Adoptive cell therapy with tum...
  • 引用
  • 發送短信
  • 推薦此
  • 打印
  • 導出紀錄
    • 導出到 RefWorks
    • 導出到 EndNoteWeb
    • 導出到 EndNote
  • Permanent link
Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types

Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types

書目詳細資料
Main Authors: Marco Donia, Troels Holz Borch, Özcan Met, Julie Westerlin Kjeldsen, Morten Nielsen, Inge Marie Svane, Anders Handrup Kverneland, Christopher Aled Chamberlain, Sofie Kirial Mørk, Cathrine Lund Lorentzen, Lise Pyndt Jørgensen, Lene Buhl Riis, Christina Westmose Yde
格式: Article
語言:English
出版: BMJ Publishing Group 2021-10-01
叢編:Journal for ImmunoTherapy of Cancer
在線閱讀:https://jitc.bmj.com/content/9/10/e003499.full
  • 持有資料
  • 實物特徵
  • 相似書籍
  • 職員瀏覽

因特網

https://jitc.bmj.com/content/9/10/e003499.full

相似書籍

  • Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy
    由: Christopher Aled Chamberlain, et al.
    出版: (2022-03-01)
  • Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma
    由: Marco Donia, et al.
    出版: (2021-07-01)
  • Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma
    由: Marco Donia, et al.
    出版: (2020-10-01)
  • Arginase-1 targeting peptide vaccine in patients with metastatic solid tumors – A phase I trial
    由: Cathrine Lund Lorentzen, et al.
    出版: (2022-10-01)
  • Long-term follow-up of anti-PD-1 naïve patients with metastatic melanoma treated with IDO/PD-L1 targeting peptide vaccine and nivolumab
    由: Mads Hald Andersen, et al.
    出版: (2023-05-01)

檢索選項

  • 檢索歷史
  • 高級檢索

查找更多

  • 瀏覽目錄
  • 按字母順序瀏覽
  • Explore Channels
  • 課程儲備
  • 新項目

需要幫助?

  • 檢索技巧
  • 咨詢台
  • 常見問題